Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Efficacy of primate humoral passive transfer in a murine model of pneumonic plague is mouse strain-dependent.

Graham VA, Hatch GJ, Bewley KR, Steeds K, Lansley A, Bate SR, Funnell SG.

J Immunol Res. 2014;2014:807564. doi: 10.1155/2014/807564. Epub 2014 Jul 6.

PMID:
25097863
[PubMed - in process]
Free PMC Article
2.

Protecting against plague: towards a next-generation vaccine.

Williamson ED, Oyston PC.

Clin Exp Immunol. 2013 Apr;172(1):1-8. doi: 10.1111/cei.12044. Review.

PMID:
23480179
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague.

Williamson ED.

Adv Prev Med. 2012;2012:365980. doi: 10.1155/2012/365980. Epub 2011 Sep 29.

PMID:
21991451
[PubMed]
Free PMC Article
4.

Developing live vaccines against plague.

Sun W, Roland KL, Curtiss R 3rd.

J Infect Dev Ctries. 2011 Sep 14;5(9):614-27. Review.

PMID:
21918302
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Model systems to study plague pathogenesis and develop new therapeutics.

Lawrenz MB.

Front Microbiol. 2010 Nov 4;1:119. doi: 10.3389/fmicb.2010.00119. eCollection 2010.

PMID:
21687720
[PubMed]
Free PMC Article
6.

Plague in Guinea pigs and its prevention by subunit vaccines.

Quenee LE, Ciletti N, Berube B, Krausz T, Elli D, Hermanas T, Schneewind O.

Am J Pathol. 2011 Apr;178(4):1689-700. doi: 10.1016/j.ajpath.2010.12.028. Epub 2011 Mar 4.

PMID:
21406168
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.

Wang S, Goguen JD, Li F, Lu S.

Vaccine. 2011 Sep 9;29(39):6802-9. doi: 10.1016/j.vaccine.2010.12.062. Epub 2011 Jan 1.

PMID:
21199697
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.

Wang S, Mboudjeka I, Goguen JD, Lu S.

Vaccine. 2010 Feb 23;28(8):2011-9. doi: 10.1016/j.vaccine.2009.10.059.

PMID:
20188257
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.

Boyer JL, Sofer-Podesta C, Ang J, Hackett NR, Chiuchiolo MJ, Senina S, Perlin D, Crystal RG.

Hum Gene Ther. 2010 Jul;21(7):891-901. doi: 10.1089/hum.2009.148.

PMID:
20180652
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine.

Sutten EL, Norimine J, Beare PA, Heinzen RA, Lopez JE, Morse K, Brayton KA, Gillespie JJ, Brown WC.

Infect Immun. 2010 Mar;78(3):1314-25. doi: 10.1128/IAI.01207-09. Epub 2010 Jan 11.

PMID:
20065028
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine.

Huang J, D'Souza AJ, Alarcon JB, Mikszta JA, Ford BM, Ferriter MS, Evans M, Stewart T, Amemiya K, Ulrich RG, Sullivan VJ.

Clin Vaccine Immunol. 2009 May;16(5):719-25. doi: 10.1128/CVI.00447-08. Epub 2009 Mar 4.

PMID:
19261773
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Stacy S, Pasquali A, Sexton VL, Cantwell AM, Kraig E, Dube PH.

J Immunol. 2008 Jul 1;181(1):109-15.

PMID:
18566375
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein.

Bartra SS, Styer KL, O'Bryant DM, Nilles ML, Hinnebusch BJ, Aballay A, Plano GV.

Infect Immun. 2008 Feb;76(2):612-22. Epub 2007 Nov 19.

PMID:
18025094
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.

Bubeck SS, Dube PH.

Clin Vaccine Immunol. 2007 Sep;14(9):1235-8. Epub 2007 Jul 25.

PMID:
17652523
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses.

Kingston R, Burke F, Robinson JH, Bedford PA, Jones SM, Knight SC, Williamson ED.

Clin Exp Immunol. 2007 Sep;149(3):561-9. Epub 2007 Jul 23.

PMID:
17645768
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, Schneewind O.

Infect Immun. 2006 Aug;74(8):4910-4.

PMID:
16861680
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.

Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS.

Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):861-6. Epub 2006 Jan 12.

PMID:
16410352
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Williamson ED, Flick-Smith HC, Lebutt C, Rowland CA, Jones SM, Waters EL, Gwyther RJ, Miller J, Packer PJ, Irving M.

Infect Immun. 2005 Jun;73(6):3598-608.

PMID:
15908389
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk